Screening for glucose intolerance in polycystic ovary syndrome: hemoglobin A1C, fasting blood glucose or oral glucose tolerance test?

Journal Article (Journal Article)

Polycystic ovary syndrome (PCOS) is a chronic condition with many reproductive, metabolic and psychological manifestations. Insulin resistance puts women with PCOS at an increased risk for developing impaired glucose tolerance (IGT) and diabetes (T2D). An oral glucose tolerance test is the preferred IGT/T2D screening test, since it is most sensitive for detecting early glucose abnormalities. The goals in detecting IGT in these women are to avoid progression to T2D, modify cardiovascular risk and prevent gestational diabetes. Periodic IGT/T2D rescreening is necessary, given their propensity for more rapid deterioration in glucose tolerance. Lifestyle intervention is first-line therapy for PCOS women with IGT. Metformin is an option if lifestyle intervention fails to have an impact, while bariatric surgery is reserved for a select set of morbidly obese patients.

Full Text

Duke Authors

Cited Authors

  • Kelley, CE; Brown, AJ; Setji, TL

Published Date

  • November 2014

Published In

Volume / Issue

  • 9 / 6

Start / End Page

  • 671 - 683

PubMed ID

  • 30736203

Electronic International Standard Serial Number (EISSN)

  • 1744-8417

Digital Object Identifier (DOI)

  • 10.1586/17446651.2014.941814

Language

  • eng

Conference Location

  • England